Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

特别是在早期非小细胞肺癌（non-small cell lung cancer ... 研究报道“Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma ...

Analysis of serum and urine miRNAs as biomarkers of cancer cachexia in pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

An ultrasensitive blood test detecting low levels of ctDNA could help to improve disease stratification in early-stage lung adenocarcinoma.

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...